Xi'an, China

Lei He

This inventor holds 1 USPTO granted patent. Top assignee: The Fourth Military Medical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei He. Retrieved from https://idiyas.com/inventor/lei-he-bt0me41z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei He - Innovator in Monoclonal Antibody Research

Introduction

Lei He is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies. His work is recognized for its potential impact on therapeutic applications.

Latest Patents

Lei He holds a patent for an "ANTI-GDF15 NEUTRALIZING MONOCLONAL ANTIBODY AND USE THEREOF." This innovative patent highlights his expertise in creating targeted therapies that could address various medical conditions.

Career Highlights

He is affiliated with The Fourth Military Medical University, where he conducts research and develops new medical technologies. His dedication to advancing medical science is evident through his innovative work and research initiatives.

Collaborations

Lei He collaborates with talented individuals in his field, including Yingqi Zhang and Meng Li. Their combined efforts contribute to the advancement of research and development in monoclonal antibody therapies.

Conclusion

Lei He is a notable inventor whose work in monoclonal antibodies showcases his commitment to medical innovation. His contributions are paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…